The Exchange had sought clarification from Nureca Limited for the quarter ended 30-Sep-2025 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company was required to clarify the following: -1. Financial results submitted in XBRL with discrepancies The response of the Company is enclosed.
NURECA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
NSE asked Nureca Limited to clarify discrepancies found in the XBRL version of its financial results for the quarter ended 30 September 2025, filed under SEBI's Listing Obligations and Disclosure Requirements. The company has submitted its written response, which is attached to the filing. The announcement does not reveal the nature of the discrepancies or the company's explanation. This is a procedural exchange between the stock exchange and the listed company, commonly triggered by formatting, tagging, or numerical mismatches between XBRL and PDF results.
Investors should watch for the company's detailed response and the audited financial numbers to confirm there is no real earnings revision, as XBRL discrepancies are often technical rather than substantive. No immediate impact on share price is expected, but unresolved clarifications can lead to further regulatory queries.